202 related articles for article (PubMed ID: 32882929)
1. Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells.
Zmeškalová A; Popelová A; Exnerová A; Železná B; Kuneš J; Maletínská L
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882929
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study.
Karnošová A; Strnadová V; Holá L; Železná B; Kuneš J; Maletínská L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445614
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of lipidized analogs of prolactin-releasing peptide with a modified C- terminal aromatic ring.
Prazienkova V; Ticha A; Blechova M; Spolcova A; Zelezna B; Maletinska L
J Physiol Pharmacol; 2016 Feb; 67(1):121-8. PubMed ID: 27010901
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-releasing peptide: a new tool for obesity treatment.
Kuneš J; Pražienková V; Popelová A; Mikulášková B; Zemenová J; Maletínská L
J Endocrinol; 2016 Aug; 230(2):R51-8. PubMed ID: 27418033
[TBL] [Abstract][Full Text] [Related]
5. Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.
Maletínská L; Nagelová V; Tichá A; Zemenová J; Pirník Z; Holubová M; Špolcová A; Mikulášková B; Blechová M; Sýkora D; Lacinová Z; Haluzík M; Železná B; Kuneš J
Int J Obes (Lond); 2015 Jun; 39(6):986-93. PubMed ID: 25771926
[TBL] [Abstract][Full Text] [Related]
6. Characterization of prolactin-releasing peptide: binding, signaling and hormone secretion in rodent pituitary cell lines endogenously expressing its receptor.
Maixnerová J; Špolcová A; Pýchová M; Blechová M; Elbert T; Rezáčová M; Zelezná B; Maletínská L
Peptides; 2011 Apr; 32(4):811-7. PubMed ID: 21185342
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.
Kořínková L; Holubová M; Neprašová B; Hrubá L; Pražienková V; Bencze M; Haluzík M; Kuneš J; Maletínská L; Železná B
J Mol Endocrinol; 2020 Feb; 64(2):77-90. PubMed ID: 31855558
[TBL] [Abstract][Full Text] [Related]
8. Lipidized Prolactin-Releasing Peptide Agonist Attenuates Hypothermia-Induced Tau Hyperphosphorylation in Neurons.
Pražienková V; Schirmer C; Holubová M; Železná B; Kuneš J; Galas MC; Maletínská L
J Alzheimers Dis; 2019; 67(4):1187-1200. PubMed ID: 30689580
[TBL] [Abstract][Full Text] [Related]
9. Peripheral administration of palmitoylated prolactin-releasing peptide induces Fos expression in hypothalamic neurons involved in energy homeostasis in NMRI male mice.
Pirnik Z; Železná B; Kiss A; Maletínská L
Brain Res; 2015 Nov; 1625():151-8. PubMed ID: 26362395
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
[TBL] [Abstract][Full Text] [Related]
11. Search for lipidized PrRP analogs with strong anorexigenic effect: In vitro and in vivo studies.
Strnadová V; Karnošová A; Blechová M; Neprašová B; Holá L; Němcová A; Myšková A; Sýkora D; Železná B; Kuneš J; Maletínská L
Neuropeptides; 2023 Apr; 98():102319. PubMed ID: 36669365
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice.
Pirník Z; Kořínková L; Osacká J; Železná B; Kuneš J; Maletínská L
Physiol Res; 2021 Aug; 70(4):579-590. PubMed ID: 34062082
[TBL] [Abstract][Full Text] [Related]
13. Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice.
Pirník Z; Kolesárová M; Železná B; Maletínská L
Neurochem Int; 2018 Jun; 116():77-84. PubMed ID: 29601847
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-releasing peptide improved leptin hypothalamic signaling in obese mice.
Holubová M; Hrubá L; Neprašová B; Majerčíková Z; Lacinová Z; Kuneš J; Maletínská L; Železná B
J Mol Endocrinol; 2018 Feb; 60(2):85-94. PubMed ID: 29233862
[TBL] [Abstract][Full Text] [Related]
15. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L
Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.
Mráziková L; Hojná S; Pačesová A; Hrubá L; Strnadová V; Neprašová B; Železná B; Kuneš J; Maletínská L
Nutr Diabetes; 2022 May; 12(1):26. PubMed ID: 35589696
[TBL] [Abstract][Full Text] [Related]
17. Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance.
Mráziková L; Hojná S; Vaculová P; Strnad Š; Vrkoslav V; Pelantová H; Kuzma M; Železná B; Kuneš J; Maletínská L
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678151
[TBL] [Abstract][Full Text] [Related]
18. Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.
Pražienková V; Popelová A; Kuneš J; Maletínská L
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653061
[TBL] [Abstract][Full Text] [Related]
19. Biological properties of prolactin-releasing peptide analogs with a modified aromatic ring of a C-terminal phenylalanine amide.
Maletínská L; Spolcová A; Maixnerová J; Blechová M; Zelezná B
Peptides; 2011 Sep; 32(9):1887-92. PubMed ID: 21872625
[TBL] [Abstract][Full Text] [Related]
20. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
